194 related articles for article (PubMed ID: 19416358)
1. Yeast, beef and pork extracts counteract Clostridium difficile toxin A enterotoxicity.
Duncan PI; Fotopoulos G; Pasche E; Porta N; Masserey Elmelegy I; Sanchez-Garcia JL; Bergonzelli GE; Corthésy-Theulaz I
FEMS Microbiol Lett; 2009 Jun; 295(2):218-25. PubMed ID: 19416358
[TBL] [Abstract][Full Text] [Related]
2. Toxigenic C. difficile induced inflammatory marker expression by human intestinal epithelial cells is asymmetrical.
Canny G; Drudy D; Macmathuna P; O'farrelly C; Baird AW
Life Sci; 2006 Jan; 78(9):920-5. PubMed ID: 16185718
[TBL] [Abstract][Full Text] [Related]
3. Fidaxomicin inhibits Clostridium difficile toxin A-mediated enteritis in the mouse ileum.
Koon HW; Ho S; Hing TC; Cheng M; Chen X; Ichikawa Y; Kelly CP; Pothoulakis C
Antimicrob Agents Chemother; 2014 Aug; 58(8):4642-50. PubMed ID: 24890583
[TBL] [Abstract][Full Text] [Related]
4. Clostridium difficile toxin: cytoskeletal changes and lactate dehydrogenase release in hepatocytes.
Grossmann EM; Longo WE; Kaminski DL; Smith GS; Murphy CE; Durham RL; Shapiro MJ; Norman JG; Mazuski JE
J Surg Res; 2000 Feb; 88(2):165-72. PubMed ID: 10644484
[TBL] [Abstract][Full Text] [Related]
5. Toxin production by and adhesive properties of Clostridium difficile isolated from humans and horses with antibiotic-associated diarrhea.
Taha S; Johansson O; Rivera Jonsson S; Heimer D; Krovacek K
Comp Immunol Microbiol Infect Dis; 2007 May; 30(3):163-74. PubMed ID: 17239950
[TBL] [Abstract][Full Text] [Related]
6. The American Cockroach Peptide Periplanetasin-2 Blocks
Hong J; Zhang P; Yoon IN; Hwang JS; Kang JK; Kim H
J Microbiol Biotechnol; 2017 Apr; 27(4):694-700. PubMed ID: 28173695
[No Abstract] [Full Text] [Related]
7. Clostridium difficile toxins and enterococcal translocation in vivo and in vitro.
Feltis BA; Garni RM; Wells CL
J Surg Res; 2001 May; 97(1):97-102. PubMed ID: 11319888
[TBL] [Abstract][Full Text] [Related]
8. Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters.
Babcock GJ; Broering TJ; Hernandez HJ; Mandell RB; Donahue K; Boatright N; Stack AM; Lowy I; Graziano R; Molrine D; Ambrosino DM; Thomas WD
Infect Immun; 2006 Nov; 74(11):6339-47. PubMed ID: 16966409
[TBL] [Abstract][Full Text] [Related]
9. Role of inducible cyclooxygenase and prostaglandins in Clostridium difficile toxin A-induced secretion and inflammation in an animal model.
Alcantara C; Stenson WF; Steiner TS; Guerrant RL
J Infect Dis; 2001 Sep; 184(5):648-52. PubMed ID: 11474431
[TBL] [Abstract][Full Text] [Related]
10. Frequency of sample submission for optimal utilization of the cell culture cytotoxicity assay for detection of Clostridium difficile toxin.
Borek AP; Aird DZ; Carroll KC
J Clin Microbiol; 2005 Jun; 43(6):2994-5. PubMed ID: 15956442
[TBL] [Abstract][Full Text] [Related]
11. Effect of biotherapeutics on cyclosporin-induced Clostridium difficile infection in mice.
Kaur S; Vaishnavi C; Ray P; Kochhar R; Prasad KK
J Gastroenterol Hepatol; 2010 Apr; 25(4):832-8. PubMed ID: 20074161
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of varying concentrations of clostridium difficile toxin A on epithelial barrier function and expression of cytokines.
Johal SS; Solomon K; Dodson S; Borriello SP; Mahida YR
J Infect Dis; 2004 Jun; 189(11):2110-9. PubMed ID: 15143480
[TBL] [Abstract][Full Text] [Related]
13. Clostridium difficile associated with pseudomembranous colitis. Occurrence in a 12-week-old infant without prior antibiotic therapy.
Adler SP; Chandrika T; Berman WF
Am J Dis Child; 1981 Sep; 135(9):820-2. PubMed ID: 7282658
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical, microbiologic, and clinicopathologic findings in horses positive and negative for Clostridium difficile infection.
Ruby R; Magdesian KG; Kass PH
J Am Vet Med Assoc; 2009 Mar; 234(6):777-84. PubMed ID: 19284345
[TBL] [Abstract][Full Text] [Related]
15. Essential involvement of IFN-gamma in Clostridium difficile toxin A-induced enteritis.
Ishida Y; Maegawa T; Kondo T; Kimura A; Iwakura Y; Nakamura S; Mukaida N
J Immunol; 2004 Mar; 172(5):3018-25. PubMed ID: 14978106
[TBL] [Abstract][Full Text] [Related]
16. New trends in Clostridium difficile virulence and pathogenesis.
Denève C; Janoir C; Poilane I; Fantinato C; Collignon A
Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S24-8. PubMed ID: 19303565
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol, it's not just for heart disease anymore.
Kerzmann A; Feig AL
ACS Chem Biol; 2006 Apr; 1(3):141-4. PubMed ID: 17163660
[TBL] [Abstract][Full Text] [Related]
18. Role of bacterial metabolism and physiology in the pathogenesis of Clostridium difficile disease.
Bongaerts GP; Lyerly DM
Microb Pathog; 1997 Apr; 22(4):253-6. PubMed ID: 9140922
[No Abstract] [Full Text] [Related]
19. [The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors].
Tunçcan OG; Ulutan F; Karakuş R
Mikrobiyol Bul; 2008 Oct; 42(4):573-83. PubMed ID: 19149078
[TBL] [Abstract][Full Text] [Related]
20. Epithelial cell I kappa B-kinase beta has an important protective role in Clostridium difficile toxin A-induced mucosal injury.
Chae S; Eckmann L; Miyamoto Y; Pothoulakis C; Karin M; Kagnoff MF
J Immunol; 2006 Jul; 177(2):1214-20. PubMed ID: 16818780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]